To address these issues, the frequency of circulating pDCs, Tregs, and ICOS+ Tregs were analyzed in GC patients in various advanced stages.
Mullier, F., Bailly, N., Chatelain, C., Chatelain, B. & Dogne, J. M. Pre-analytical issues in the measurement of circulating microparticles: current recommendations and pending questions.
The following main technical issues regarding the measurement of circulating levels of miRNAs will have to be considered: advantages and drawbacks of assessing miRNAs in whole blood versus plasma, and appropriate normalization procedure.
In this review, we focus on studies and technical issues concerning the evaluation of circulating miRNAs in blood, plasma, and serum, the biological fluids most analyzed as a source of cell-free miRNAs.
Thus, in this study our focus was to develop a strategy to validate a large panel of ligand binding (sandwich ELISA) assays (LBAs) (Shah, 2007) and to characterise sample handling issues associated with analysis of circulating soluble angiogenesis regulators such as stability and influence of platelets (Nayeri et al, 2002; Findlay, 2009; Mahler et al, 2009).
Another issue is the presence of circulating cancer progenitor cells.
The major issue is the identification of the different types of circulating endothelial cells (CECs) issued respectively from the vessel wall or from bone marrow progenitors.
Moreover, we discuss current and future issues which may benefit from assessment of circulating biomarkers and lead to improved clinical care for patients with diffuse glioma.
While some issues remain unresolved regarding the monitoring of circulating miRNA as biomarkers or the efficacy of miRNA delivery, novel trials for noninvasive miRNA-based diagnosis and for highly efficacious "miRNA therapeutics" will be a worthwhile step for clinical applications in the near future.
34 Our findings also do not address the separate issue of the value of measurement of circulating C reactive protein in prediction of long term vascular risk.
